Apoptosis induction by arsenic: mechanisms of action and possible clinicalapplications for treating therapy-resistant cancers

Authors
Citation
A. Bode et Zg. Dong, Apoptosis induction by arsenic: mechanisms of action and possible clinicalapplications for treating therapy-resistant cancers, DRUG RESIST, 3(1), 2000, pp. 21-29
Citations number
81
Categorie Soggetti
Pharmacology & Toxicology
Journal title
DRUG RESISTANCE UPDATES
ISSN journal
13687646 → ACNP
Volume
3
Issue
1
Year of publication
2000
Pages
21 - 29
Database
ISI
SICI code
1368-7646(2000)3:1<21:AIBAMO>2.0.ZU;2-F
Abstract
Arsenic, a known carcinogen, may be useful in cancer treatment. Arsenic may be effective in counteracting drug resistance because it appears to induce apoptosis in tumor cells independently of p53 activation, thereby allowing it to be directed against p53-defective cancers. The role of MAP kinases i n arsenic-induced apoptosis in tumor cells is important and may be influenc ed by reactive oxygen species or glutathione. This review focuses on recent findings from this and other laboratories regarding the mechanism(s) of ar senic-induced apoptosis in tumor cells and considers their relevance in the clinical treatment of therapy-resistant cancers. (C) 2000 Harcourt Publish ers Ltd.